Search

Your search keyword '"ADULT respiratory distress syndrome"' showing total 1,410 results

Search Constraints

Start Over You searched for: Descriptor "ADULT respiratory distress syndrome" Remove constraint Descriptor: "ADULT respiratory distress syndrome" Database Gale General OneFile Remove constraint Database: Gale General OneFile
1,410 results on '"ADULT respiratory distress syndrome"'

Search Results

1. Predictors and Outcomes of Acute Kidney Injury after Cardiac Surgery

2. Ventilator dyssynchrony - Detection, pathophysiology, and clinical relevance: A Narrative review

3. A comment on 'Indian Resuscitation Council suggested guidelines for Comprehensive Cardiopulmonary Life Support for suspected or confirmed coronavirus disease patient'

5. Chengdu University of Traditional Chinese Medicine Researchers Have Published New Data on Liposomes (Baicalin Liposome Alleviates Lipopolysaccharide-Induced Acute Lung Injury in Mice via Inhibiting TLR4/JNK/ERK/NF-kB Pathway) (Baicalin Liposome ...)

6. Reports on Avian Influenza (Bird Flu) from Airlangga University Provide New Insights (Bone marrow-derived mesenchymal stem cells attenuate pulmonary inflammation and lung damage caused by highly pathogenic avian influenza A/H5N1 virus in BALB/c ...)

7. Investigators at Shanghai Jiao Tong University School of Medicine Target Acute Lung Injury (PIM1 inhibition attenuated endotoxin-induced acute lung injury through modulating ELK3/ICAM1 axis on pulmonary microvascular endothelial cells)

8. Findings in Escherichia coli Infections Reported from Newcastle University (Src kinase inhibition with dasatinib impairs neutrophil function and clearance of Escherichia coli infection in a murine model of acute lung injury)

9. Research Study Findings from Zunyi Medical University Update Understanding of Acute Lung Injury (Identification of atypical mitogen-activated protein kinase MAPK4 as a novel regulator in acute lung injury)

10. Unilateral orbital emphysema in a COVID-19 patient

11. Mie University Researchers Publish Findings in Sepsis (The Role of Innate Lymphoid Cells in the Regulation of Immune Homeostasis in Sepsis-Mediated Lung Inflammation)

12. Investigators at University of Padua Zero in on Neurologic Diseases and Conditions (Practical approach to respiratory emergencies in neurological diseases)

13. ImStem obtains from AgeX a royalty-bearing sublicense for ESC line ESI-053

14. Second Clinical Medical College of Jinan University Researchers Update Knowledge of Acute Lung Injury (Knockdown of lncRNA MALAT1 Alleviates LPS-Induced Acute Lung Injury via Inhibiting Apoptosis Through the miR-194-5p/FOXP2 Axis)

16. New Acute Lung Injury Study Findings Have Been Reported by Researchers at Capital Medical University (Targeting Nox4 Alleviates Sepsis-induced Acute Lung Injury Via Attenuation of Redox-sensitive Activation of Camkii/erk1/2/mlck and Endothelial ...)

17. Pluristem announces formation of COVID-19 Steering Committee

18. NIH initiates phase 3 clinical trial to test immune modulators for treatment of COVID-19

19. Researchers from Chinese Academy of Sciences Describe Findings in Acute Lung Injury (Paeonol Loaded Cyclodextrin Metal-organic Framework Particles for Treatment of Acute Lung Injury Via Inhalation)

20. Novellus Therapeutics licenses iMSCs to Citius Pharmaceuticals' NoveCite

21. Mesoblast: Phase 3 trial of remestemcel-L surpasses 50% enrollment

22. Sorrento Therapeutics enters exclusive license agreement with PSC for MSC rights

23. Citius Pharmaceuticals signs licensing agreement with Novellus Therapeutics

24. Pluristem receives approval to commence patient enrollment in COVID-19 trial

25. Data from First Affiliated Hospital of Zhengzhou University Advance Knowledge in Acute Lung Injury (Adipose-derived mesenchymal stem cells attenuate acute lung injury and improve the gut microbiota in septic rats)

26. Athersys: MultiStem cell therapy granted RMAT designation from FDA

27. Researchers at Shandong University Target Acute Lung Injury (PAD4 selective inhibitor TDFA protects lipopolysaccharide-induced acute lung injury by modulating nuclear p65 localization in epithelial cells)

29. Athersys CEO 'confident' drug will deliver in COVID-19, Spectrum News 1 reports

31. Mesoblast says DSMB recommends continuation of remestemcel-L Phase 3 trial

32. Mesoblast receives ethics approval to treat COVID-19 patients in Australia

33. Recent Findings from Odisha Highlight Research in Respiratory Distress Syndrome (Factors Leading to Early Preterm Premature Rupture of Membranes in a Tertiary Care Centre in Eastern India: A Prospective Study)

35. Pluristem launches FDA-cleared COVID-19 Expanded Access Program

36. Reports on Pulmonary Edema from Zhejiang University School of Medicine Provide New Insights (Neurogenic pulmonary edema following acute stroke: The progress and perspective)

39. Reports from Vanderbilt University Medical Center Highlight Recent Research in Environmental Research (Long-term ozone exposure is positively associated with telomere length in critically ill patients)

40. Athersys partner Healios says ARDS cohort of ONE-BRIDGE trial fully enrolled

41. Pluristem expands COVID-19 program to Europe

42. Aerpio announces second clinical trial to evaluate razuprotafib

43. Researchers at Chinese People's Liberation Army (PLA) General Hospital Target COVID-19 (Mesenchymal stem cells: current clinical progress in ARDS and COVID-19)

44. Study Data from University Hospital Zurich Update Understanding of COVID-19 (Lessons learned from the mechanisms of posttraumatic inflammation extrapolated to the inflammatory response in COVID-19: a review)

45. Researchers' Work from University of Alabama Birmingham Focuses on Biomarkers (Microrna-mediated Inflammation and Coagulation Effects In Rats Exposed To an Inhaled Analog of Sulfur Mustard)

46. Edesa Biotech files IND application with FDA for EB05 clinical study

47. 9 Meters Biopharma's larazotide patent positive in ALI/ARDS, says SunTrust

48. Arch Biopartners announces first U.S. site for Phase II trial for LSALT peptide

49. 9 Meters Biopharma issued larazotide-related patent from USPTO

50. Pluristem sees data from U.S. PLX-PAD study in COVID-19 in Q4

Catalog

Books, media, physical & digital resources